Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Averitas Pharma
Averitas Pharma
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Qutenza
Capsaicin
2009-11-16
2023-2030
Neuralgia
,
Diabetic neuropathies
,
Herpes zoster
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Capsaicin
peripheral nervous system diseases
,
breast neoplasms
,
neuralgia
,
osteoarthritis
Nepidermin
healthy volunteers/patients
,
colorectal neoplasms
,
non-small-cell lung carcinoma
,
hiv infections
,
pain
,
psoriasis
,
lung neoplasms
,
leukemia
,
neoplasms
,
cancer pain
,
low back pain
,
back pain
,
sarcoma
,
pancreatic neoplasms
,
prostatic neoplasms
,
infections
,
acquired immunodeficiency syndrome
,
communicable diseases
,
myeloid leukemia acute
,
stroke
,
embolism
,
embolic stroke
,
lymphoma
,
b-cell chronic lymphocytic leukemia
,
prolymphocytic leukemia t-cell
,
lymphoid leukemia
,
knee osteoarthritis
,
osteoarthritis
,
chronic pain
,
atrial fibrillation
,
coronary artery disease
,
peripheral arterial disease
,
peripheral vascular diseases
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use